Logo image of WK

WORKIVA INC (WK) Stock Fundamental Analysis

NYSE:WK - New York Stock Exchange, Inc. - US98139A1051 - Common Stock - Currency: USD

71.26  +1.17 (+1.67%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to WK. WK was compared to 283 industry peers in the Software industry. WK has a bad profitability rating. Also its financial health evaluation is rather negative. WK is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

WK had positive earnings in the past year.
WK had a positive operating cash flow in the past year.
WK had negative earnings in each of the past 5 years.
Each year in the past 5 years WK had a positive operating cash flow.
WK Yearly Net Income VS EBIT VS OCF VS FCFWK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.00%, WK is in line with its industry, outperforming 47.70% of the companies in the same industry.
Industry RankSector Rank
ROA -5%
ROE N/A
ROIC N/A
ROA(3y)-8.53%
ROA(5y)-7.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WK Yearly ROA, ROE, ROICWK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K -1K -1.5K

1.3 Margins

WK's Gross Margin of 76.75% is fine compared to the rest of the industry. WK outperforms 72.79% of its industry peers.
In the last couple of years the Gross Margin of WK has remained more or less at the same level.
WK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.05%
GM growth 5Y1.43%
WK Yearly Profit, Operating, Gross MarginsWK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

3

2. Health

2.1 Basic Checks

WK does not have a ROIC to compare to the WACC, probably because it is not profitable.
WK has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WK has been increased compared to 5 years ago.
The debt/assets ratio for WK has been reduced compared to a year ago.
WK Yearly Shares OutstandingWK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
WK Yearly Total Debt VS Total AssetsWK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

WK has an Altman-Z score of 1.70. This is a bad value and indicates that WK is not financially healthy and even has some risk of bankruptcy.
WK has a Altman-Z score of 1.70. This is comparable to the rest of the industry: WK outperforms 45.58% of its industry peers.
WK has a debt to FCF ratio of 14.60. This is a negative value and a sign of low solvency as WK would need 14.60 years to pay back of all of its debts.
WK has a Debt to FCF ratio of 14.60. This is comparable to the rest of the industry: WK outperforms 47.35% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 14.6
Altman-Z 1.7
ROIC/WACCN/A
WACC10.12%
WK Yearly LT Debt VS Equity VS FCFWK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.78 indicates that WK should not have too much problems paying its short term obligations.
WK has a Current ratio of 1.78. This is comparable to the rest of the industry: WK outperforms 56.18% of its industry peers.
WK has a Quick Ratio of 1.78. This is a normal value and indicates that WK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.78, WK is in line with its industry, outperforming 56.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.78
WK Yearly Current Assets VS Current LiabilitesWK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

WK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 863.64%, which is quite impressive.
Measured over the past years, WK shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.48% on average per year.
Looking at the last year, WK shows a quite strong growth in Revenue. The Revenue has grown by 17.36% in the last year.
WK shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.92% yearly.
EPS 1Y (TTM)863.64%
EPS 3Y35.48%
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.55%
Revenue growth 5Y19.92%
Sales Q2Q%17.43%

3.2 Future

The Earnings Per Share is expected to grow by 46.07% on average over the next years. This is a very strong growth
Based on estimates for the next years, WK will show a quite strong growth in Revenue. The Revenue will grow by 18.16% on average per year.
EPS Next Y16.96%
EPS Next 2Y37.73%
EPS Next 3Y52.94%
EPS Next 5Y46.07%
Revenue Next Year18.02%
Revenue Next 2Y17.16%
Revenue Next 3Y17.86%
Revenue Next 5Y18.16%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
WK Yearly Revenue VS EstimatesWK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
WK Yearly EPS VS EstimatesWK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 84.83, which means the current valuation is very expensive for WK.
WK's Price/Earnings is on the same level as the industry average.
When comparing the Price/Earnings ratio of WK to the average of the S&P500 Index (26.70), we can say WK is valued expensively.
With a Price/Forward Earnings ratio of 40.83, WK can be considered very expensive at the moment.
WK's Price/Forward Earnings ratio is in line with the industry average.
WK's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.49.
Industry RankSector Rank
PE 84.83
Fwd PE 40.83
WK Price Earnings VS Forward Price EarningsWK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

WK's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 74.39
EV/EBITDA N/A
WK Per share dataWK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WK does not grow enough to justify the current Price/Earnings ratio.
WK's earnings are expected to grow with 52.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)5
PEG (5Y)N/A
EPS Next 2Y37.73%
EPS Next 3Y52.94%

0

5. Dividend

5.1 Amount

No dividends for WK!.
Industry RankSector Rank
Dividend Yield N/A

WORKIVA INC

NYSE:WK (5/20/2025, 2:06:43 PM)

71.26

+1.17 (+1.67%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-30 2025-07-30/amc
Inst Owners96.25%
Inst Owner Change0.93%
Ins Owners1.93%
Ins Owner Change5.86%
Market Cap3.97B
Analysts88
Price Target103.62 (45.41%)
Short Float %4.35%
Short Ratio2.68
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)42.64%
Min EPS beat(2)-3.5%
Max EPS beat(2)88.78%
EPS beat(4)1
Avg EPS beat(4)15.48%
Min EPS beat(4)-11.74%
Max EPS beat(4)88.78%
EPS beat(8)4
Avg EPS beat(8)-176.88%
EPS beat(12)8
Avg EPS beat(12)-92.27%
EPS beat(16)12
Avg EPS beat(16)27.07%
Revenue beat(2)0
Avg Revenue beat(2)-1.24%
Min Revenue beat(2)-1.84%
Max Revenue beat(2)-0.63%
Revenue beat(4)0
Avg Revenue beat(4)-1.35%
Min Revenue beat(4)-1.84%
Max Revenue beat(4)-0.63%
Revenue beat(8)0
Avg Revenue beat(8)-1.55%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)5
Avg Revenue beat(16)-0.92%
PT rev (1m)-13.81%
PT rev (3m)-17.14%
EPS NQ rev (1m)-29.8%
EPS NQ rev (3m)-44.66%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)-17.04%
Revenue NQ rev (1m)0.15%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.65%
Valuation
Industry RankSector Rank
PE 84.83
Fwd PE 40.83
P/S 5.16
P/FCF 74.39
P/OCF 71.58
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.84
EY1.18%
EPS(NY)1.75
Fwd EY2.45%
FCF(TTM)0.96
FCFY1.34%
OCF(TTM)1
OCFY1.4%
SpS13.8
BVpS-1.36
TBVpS-5.41
PEG (NY)5
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.75%
FCFM 6.94%
ROA(3y)-8.53%
ROA(5y)-7.44%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.05%
GM growth 5Y1.43%
F-Score7
Asset Turnover0.59
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 14.6
Debt/EBITDA N/A
Cap/Depr 18.48%
Cap/Sales 0.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.78
Quick Ratio 1.78
Altman-Z 1.7
F-Score7
WACC10.12%
ROIC/WACCN/A
Cap/Depr(3y)23.58%
Cap/Depr(5y)38.56%
Cap/Sales(3y)0.42%
Cap/Sales(5y)0.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)863.64%
EPS 3Y35.48%
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.96%
EPS Next 2Y37.73%
EPS Next 3Y52.94%
EPS Next 5Y46.07%
Revenue 1Y (TTM)17.36%
Revenue growth 3Y18.55%
Revenue growth 5Y19.92%
Sales Q2Q%17.43%
Revenue Next Year18.02%
Revenue Next 2Y17.16%
Revenue Next 3Y17.86%
Revenue Next 5Y18.16%
EBIT growth 1Y-24.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year66.07%
EBIT Next 3Y84.54%
EBIT Next 5Y67.49%
FCF growth 1Y268.29%
FCF growth 3Y23.18%
FCF growth 5Y26.04%
OCF growth 1Y211.3%
OCF growth 3Y20.73%
OCF growth 5Y23.19%